<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261006071325N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-11-16</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>Comparing corrective exercises alone with corrective exercises plus Graston therapy for improving posture, breathing, and quality of life in men with upper crossed syndrome</public_title>
      <acronym></acronym>
      <scientific_title>Effect of Eight Weeks of Corrective Exercises (NASM) With and Without Instrument-Assisted Soft Tissue Mobilization (Graston Technique) on Postural Structure, Respiratory Function, and Quality of Life in Men with Upper Crossed Syndrome</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-11-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/94237</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: Following purposive and convenience sampling and assessment of the inclusion and exclusion criteria, 30 men aged 20–45 years with upper crossed syndrome will be enrolled in the study. After baseline assessments, participants will be randomly allocated to two groups of 15 participants each using a lottery method with a 1:1 allocation ratio. The first group will receive NASM corrective exercises combined with instrument-assisted soft tissue mobilization (Graston technique), while the second group will receive NASM corrective exercises alone. The unit of randomization will be the individual participant, and no stratification will be applied. For random allocation, 30 identical slips of paper will be prepared, with 15 labeled as Group 1 and 15 as Group 2. All slips will be folded identically, thoroughly mixed, and placed in an opaque container. After confirmation of eligibility and completion of baseline assessments, one slip will be drawn for each participant without replacement to determine group allocation. To ensure allocation concealment, the contents of the slips will remain hidden until the time of drawing, and neither participants nor assessors will know the assigned group before allocation.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: Upper Crossed Syndrome (UCS). Condition 2: Upper Crossed Syndrome (UCS).</hc_freetext>
      <i_freetext>Intervention 1: Participants in this group received a NASM-based corrective exercise program without Graston technique. The intervention consisted of 24 supervised sessions over 8 weeks, with three sessions per week. Each session lasted approximately 45 minutes and included warm-up, main corrective exercises, and cool-down. The exercise program followed the NASM corrective exercise protocol. Intervention 2: Intervention group: Participants in this group receive a NASM-based corrective exercise program combined with instrument-assisted soft tissue mobilization using the Graston technique. Each session consists of 45 minutes of NASM corrective exercises followed by 15 minutes of Graston technique. The intervention comprises 24 sessions over 8 weeks, with three sessions per week. The total duration of each session is 60 minutes.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is A final decision regarding the sharing of de-identified individual participant data has not yet been made. The possibility of sharing these data will be considered in the future, taking into account participant confidentiality, ethical requirements, and applicable institutional policies.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mehdi Taheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>isfehan-Kheshavarzi</address>
        <city>Isfehan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174739852</zip>
        <telephone>+98 916 032 5736</telephone>
        <email>mehditaheri81007@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mehdi Taheri</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Iran-Isfehan-Kheshavarzi</address>
        <city>Isfehan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174739852</zip>
        <telephone>+98 916 032 5736</telephone>
        <email>mehditaheri81007@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Men aged 20 to 45 years with upper crossed syndrome diagnosed by a physiotherapist or corrective exercise specialist.
Presence of at least two postural abnormalities: forward head posture, forward shoulder posture, or thoracic kyphosis.
Providing informed consent to participate in the study.
Absence of acute or chronic respiratory, cardiac, or neurological diseases that prevent participation in the exercise program.
No sensitivity to massage.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>45 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>History of surgery involving the spine, shoulder, or neck within the previous six months.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M40.0</hc_code>
      <hc_code>R29.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Postural kyphosis</hc_keyword>
      <hc_keyword>Abnormal posture</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Participants in this group received a NASM-based corrective exercise program without Graston technique. The intervention consisted of 24 supervised sessions over 8 weeks, with three sessions per week. Each session lasted approximately 45 minutes and included warm-up, main corrective exercises, and cool-down. The exercise program followed the NASM corrective exercise protocol.</i_keyword>
      <i_keyword>Intervention group: Participants in this group receive a NASM-based corrective exercise program combined with instrument-assisted soft tissue mobilization using the Graston technique. Each session consists of 45 minutes of NASM corrective exercises followed by 15 minutes of Graston technique. The intervention comprises 24 sessions over 8 weeks, with three sessions per week. The total duration of each session is 60 minutes.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Change in pulmonary function from baseline to the end of the 8-week intervention, assessed using forced vital capacity (FVC), forced expiratory volume in one second (FEV1), the FEV1/FVC ratio, and vital capacity (VC). Timepoint: At baseline (before the intervention) and immediately after completion of the 8-week intervention (24 sessions). Method of measurement: Pulmonary function will be assessed using a digital spirometer (Spirolab MIR, Italy). The measured indices will include forced vital capacity (FVC), forced expiratory volume in one second (FEV1), the FEV1/FVC ratio, and vital capacity (VC). The device will be calibrated using a standard 3-liter syringe. Participants will be tested in a seated position after receiving instructions on proper breathing maneuvers. At least three spirometry trials will be performed, and the mean value of each respiratory index will be recorded. All tests will be conducted according to ATS/ERS standardized guidelines.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Forward head posture angle. Timepoint: At baseline (before the intervention) and immediately after completion of the 8-week intervention. Method of measurement: Forward head posture was assessed using photogrammetry and Kinovea software (version 2025.2). A Samsung Galaxy A12 smartphone camera mounted on a tripod was positioned 1.5 meters from the participant, with the lens center approximately at the level of the seventh cervical vertebra (C7) and perpendicular to the sagittal plane. The C7 spinous process and the midpoint of the ear tragus were identified by palpation and marked with skin markers. Participants stood in a natural, relaxed position, with their feet shoulder-width apart and arms hanging freely at their sides. A lateral photograph was taken without conscious correction of head or neck posture. The image was analyzed using the angle measurement tool in Kinovea. The angle vertex was placed at C7, and the acute angle between a vertical line passing upward through C7 and a line connecting C7 to the midpoint of the ear tragus was measured in degrees. Each image was analyzed three times, and the mean of the three measurements was recorded as the final value.</sec_outcome>
      <sec_outcome>Forward shoulder posture angle (Rounded Shoulder Angle). Timepoint: At baseline (before the intervention) and immediately after completion of the 8-week intervention. Method of measurement: Forward shoulder posture was assessed using photogrammetry and Kinovea software (version 2025.2). A Samsung Galaxy A12 smartphone camera mounted on a tripod was positioned 1.5 meters from the participant, with the lens center approximately at the level of C7 and the shoulder, perpendicular to the participant's sagittal plane. The spinous process of the seventh cervical vertebra (C7) and the acromion process on the side being evaluated were identified by palpation and marked with skin markers. Participants stood naturally and comfortably in a lateral position, with the evaluated side facing the camera, feet shoulder-width apart, and arms hanging freely at their sides. A lateral photograph was taken without conscious correction of shoulder posture. The image was analyzed using the angle measurement tool in Kinovea. The angle vertex was placed at C7, and the angle between a vertical line extending downward from C7 and a line connecting C7 to the acromion process was measured in degrees. Each image was analyzed three times, and the mean of the three measurements was recorded as the final value.</sec_outcome>
      <sec_outcome>Thoracic kyphosis angle. Timepoint: At baseline (before the intervention) and immediately after completion of the 8-week intervention. Method of measurement: Thoracic kyphosis was assessed using a 60-cm flexible ruler (Flexicurve, Kearing model). Participants stood in a natural and comfortable position, with their feet shoulder-width apart, knees extended, arms hanging naturally at their sides, and eyes looking straight ahead. The spinous processes of the seventh cervical vertebra (C7) and the twelfth thoracic vertebra (T12) were identified by palpation. The measurement range extended from T1 to T12. The flexible ruler was gently placed along the thoracic spine without applying additional pressure, following the natural spinal curvature. The ruler was molded three times to ensure an accurate fit. It was then removed without altering its shape and transferred onto a white A4 sheet. The inner contour of the ruler was traced using a fine pen. The kyphosis angle was calculated using the standard two-curve method by drawing two tangent lines to the upper and lower portions of the curve and measuring the angle between the perpendiculars to these tangent lines. The measurement procedure was repeated three times, and the mean value was recorded as the final thoracic kyphosis angle.</sec_outcome>
      <sec_outcome>Health-related quality of life assessed using the Persian version of the 36-Item Short Form Health Survey (SF-36). Timepoint: At baseline (before the intervention) and immediately after completion of the 8-week intervention. Method of measurement: Health-related quality of life was assessed using the Persian version of the 36-Item Short Form Health Survey (SF-36). The questionnaire consists of 36 items covering eight domains: physical functioning, role limitations due to physical health problems, bodily pain, general health, vitality, social functioning, role limitations due to emotional problems, and mental health. One additional item assesses perceived changes in health compared with the previous year and is not included in the calculation of the eight domain scores. The questionnaire was administered before the intervention and after completion of the 8-week intervention in a quiet environment, using standardized instructions. Participants completed the questionnaire based on their physical, psychological, and social status. Any necessary clarification was provided without influencing their responses. Scoring followed the SF-36 guidelines. Responses were coded according to item direction, and reverse-coded items were recoded accordingly. Scores were transformed to a 0–100 scale, with higher scores indicating better health-related quality of life. The mean score for each of the eight domains was calculated. The overall quality-of-life score was obtained by calculating the arithmetic mean of the eight domain scores.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Self-funded by the researcher</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-09-15</approval_date>
        <contact_name>Ethics Committee of Islamic Azad University, Isfahan (Khorasgan) Branch</contact_name>
        <contact_address>University Boulevard, Arghavanieh, East Jey Street, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
